The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

BEAM FINANCIAL STATEMENTS

Beam Therapeutics Inc — balance sheet, income statement and cash flow trends

BEAMBeam Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-250 M0250 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue156 M $Gross Profit29.5 M $ · 19%Operating Income-378 M $ · -242%Pre-tax Income-85.4 M $ · -55%Net Income to Owners-85.4 M $ · -55%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue156 M $+158.9%
Gross Profit29.5 M $—
Operating Income-378 M $—
EBITDA-60.3 M $—
Net Income to Owners-85.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B1.5 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets1.4 B
  • Equity1.1 B $77%
  • Current Liabilities80.9 M $6%
  • Long-term Liabilities238.3 M $17%

Key Figures

YoY change
Total Assets1.4 B $-0.3%
Total Liabilities319.2 M $-7.3%
Total Equity1.1 B $+2.0%
Cash & ST Investments1.2 B $+0.2%
Total Debt247.4 M $+59.8%
Net Debt27.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-400 M-200 M0200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-300 M-200 M-100 M0-359.4 M $Operating189.5 M $Investing107.7 M $Financing-62.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-359.4 M $—
Capital Expenditures13.4 M $+24.6%
Free Cash Flow-372.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on BEAM

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.